Pharmacotherapy of attention deficit hyperactivity disorder in adults

CNS Drugs

Volumn 9, Issue 5, 1998, Pages 347-356

  Wilens, Timothy E ^a   Biederman, Joseph ^a   Spencer, Thomas J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMINO ACID; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ATOMOXETINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CENTRAL STIMULANT AGENT; CLONIDINE; DESIPRAMINE; GUANFACINE; LEVODOPA; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; NOMIFENSINE; NORTRIPTYLINE; PARGYLINE; PEMOLINE; PROPRANOLOL DERIVATIVE; S ADENOSYLMETHIONINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TYROSINE; VENLAFAXINE;

ADOLESCENT; ADULT; ANOREXIA; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; HEADACHE; HUMAN; INSOMNIA; MULTICENTER STUDY; NEUROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SINGLE BLIND PROCEDURE; WEIGHT REDUCTION;

EID: 0031747505     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199809050-00002     Document Type: Review

References (56)

1. Bauermeister JJ, Canino G, Bird H. Epidemiology of disruptive behavior disorders. In: Greenhill L. editor. Child and adolescent psychiatric clinics of North America. Philadelphia: WB Saunders Company, 1994: 177-94
2. Murphy K, Barkley R. Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: implications for clinical diagnosis. J Attention Disord 1996; 1: 147-61
3. Faraone SV, Biederman J, Chen WJ, et al. Segregation analysis of attention deficit hyperactivity disorder. Psychiatr Genet 1992; 2: 257-75
4. Weiss G, Hechtman LT. Hyperactive children grown up. New York: The Guilford Press, 1986
5. Mannuzza S, Klein RG, Bonagura N, et al. Hyperactive boys almost grown up. V. Replication of psychiatric status. Arch Gen Psychiatry 1991; 48: 77-83
6. Manuzza S, Klein RG, Bessler A, et al. Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993; 50: 565-76
7. Biederman J, Faraone SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150: 1792-8
8. Biederman J, Wilens TE, Mick E, et al. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 1995; 152: 1652-8
9. Spencer T, Biederman J, Wilens TE, et al. Is attention deficit hyperactivity disorder in adults a valid diagnosis? Harv Rev Psychiatry 1994; 1: 326-35
10. American Psychiatric Association, Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association Press, 1994
11. Brown T. Brown Attention Deficit Disorder Scales. San Antonio: The Psychological Corporation, 1995
12. Ward MF, Wender PH, Reimherr FW. The Wender Utah rating scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150: 885-90
13. Millstein R, Wilens T, Biederman J, et al. Presenting symptoms in ADHD in clinically referred adults with ADHD. J Attent Dis. In press
14. Ratey JJ, Greenberg MS, Bemporad JR, et al. Unrecognized attention-deficit hyperactivity disorder in adults presenting for outpatient psychotherapy. J Child Adolesc Psychopharmacol 1992; 2: 267-75
15. McDermott SP, Wilens TE. Cognitive and emotional impediments to treating the adult with ADHD: a cognitive therapy perspective. In: Brown T, editor. Subtypes of attention deficit disorders in children, adolescents, and adults. Washington, DC: American Psychiatric Press, Inc. In press
16. Spencer T, Biederman J, Wilens T, et al. Pharmacotherapy of attention deficit disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996; 35: 409-32
17. Wood DR, Reimherr FW, Wender PH, et al. Diagnosis and treatment of minimal brain dysfunction in adults. Arch Gen Psychiatry 1976; 33: 1453-60
18. Wender PH, Reimherr FW, Wood DR. Attention deficit disorder ('minimal brain dysfunction') in adults: a replication study of diagnosis and drug treatment. Arch Gen Psychiatry 1981; 38: 449-56
19. Wender PH, Reimherr FW, Wood D, et al. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry 1985; 142: 547-52
20. Gualtieri CT, Ondrusek MG, Finley C. Attention deficit disorder in adults. Clin Neuropharmacol 1985; 8: 343-56
21. Mattes JA, Boswell L, Oliver H. Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 1984; 41: 1059-63
22. Shekini WO, Asarnow RF, Hess E, et al. A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry 1990; 31: 416-25
23. Spencer T, Wilens TE, Biederman J, et al. A double-blind, cross-over comparison of methylphenidate and placebo in adults with childhood onset attention deficit hyperactivity disorder. Arch Gen Psychiatry 1995; 52: 434-43
24. Iaboni F, Bouffard R, Minde K, et al. The efficacy of methylphenidate in treating adults with attention deficit/hyperactivity disorder [abstract]. Proceedings of the American Academy of Child and Adolescent Psychiatry: 1996 Oct; Philadelphia
25. Wilens T, Frazier JJP, Spencer T, et al. A double-blind comparison of pemoline in adults with ADHD: preliminary results [abstract]. Proceedings of the American Academy of Child and Adolescent Psychiatry: 1996 Oct; Philadelphia
26. Wilens TE, Biederman J. The stimulants. In: Shafer D, editor. The psychiatric clinics of North America. Philadelphia: WB Saunders, 1992: 191-222
27. Wender P, Reimherr F, Czaijkowski L, et al. A longterm trial of methylphenidate in the treatment of ADHD adults: a placebo-controlled trial and six-month follow-up [abstract]. American College of Neuropharmacology: 1995 Dec; Puerto Rico
28. Gualtieri CT, Hicks RE, Patrick K, et al. Clinical correlates of methylphenidate hlood levels. Ther Drug Monit 1984; 6: 379-92
29. Langer DH, Sweeney KP, Bartenbach DE, et al. Evidence of lack of abuse or dependence following pemoline treatment: results of a retrospective survey. Drug Alcohol Depend 1986; 17: 213-27
30. Taylor E, Schachar R, Thorley G, et al. Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour. Psychol Med 1987; 17: 121-43
31. Wilens TE, Biederman J, Mick E, et al. A systematic assessment of tricyclic antidepressants in the treatment of adult attention deficit hyperactivity disorder. J Nerv Ment Dis 1995; 184: 48-50
32. Wilens T, Biderman J, Prince J, et al. A double-blind, placebo-controlled trial of desipramine for adults with ADHD. Am J Psychiatry 1996; 153: 1147-53
33. Wender PH, Reimherr FW. Bupropion treatment of attention deficit hyperactivity disorder in adults. Am J Psychiatry 1990; 147: 1018-20
34. Wender PH, Wood DR, Reimherr FW, et al. An open trial of pargyline in the treatment of attention deficit disorder, residual type. Psychiatry Res 1983; 9: 329-36
35. Wender PH, Wood DR, Reimherr FW. Pharmacological treatment of attention deficit disorder residual type (ADD.RT, 'minimal brain dysfunction', 'hyperactivity') in adults. Psychopharmacol Bull 1985; 21: 222-30
36. Ernst M, Liebenauer L, Jons P, et al. Selegiline in adults with attention deficit hyperactivity disorder: clinical efficacy and safety. Psychopharmacol Bull 1996; 32: 327-34
37. Spencer T, Biederman J, Wilens T, et al. Tolerability and efficacy of tomoxetine for adults with attention deficit hyperactivity disorder. Am J Psychiatry. In press
38. Shekim WO, Masterson A, Cantwell DP, et al. Nomifensine maleate in adult attention deficit disorder. J Nerv Ment Dis 1989; 177: 296-9
39. Shekim WO, Antun F, Hanna GL, et al. S-adenosyl-1-methionine (SAM) in adults with ADHD, RS: preliminary results from an open trial. Psychopharmacol Bull 1990; 26: 249-53
40. Adler LA, Resnick S, Kunz M, et al. Open label trial of venlafaxine in adults with attention deficit disorder. Psychopharmacol Bull 1995; 31: 785-8
41. Findling RL, Schwartz MA, Flannery DJ, et al. Venlafaxine in adults with attention deficit/hyperactivity disorder: an open clinical trial. J Clin Psychiatry 1996; 57: 184-9
42. Reimherr FW, Hedges DW, Strong RE, et al. An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder [abstract]. New Clinical Drug Evaluation Unit program 35th Annual Meeting: 1995 May; Orlando
43. Mattes JA. Propranolol for adults with temper outbursts and residual attention deficit disorder. J Clin Psychopharmacol 1986; 6: 299-302
44. Reimherr FW, Wender PH, Wood DR, et al. An open trial of L-tyrosine in the treatment of attention deficit hyperactivity disorder, residual type. Am J Psychiatry 1987; 144: 1071-3
45. Wood D, Reimherr J, Wender PH. Effects of levodopa on attention deficit disorder, residual type. Psychiatry Res 1982; 6: 13-20
46. Wood DR, Reimherr FW, Wender PH. The treatment of attention deficit disorder with d,1-phenylalanine. Psychiatry Res 1985; 16: 21-6
47. Trott GE, Friese HJ, Menzel M, et al. Use of moclobemide in children with attention deficit hyperctivity disorder [in German]. Z Kinder Jugendpsychiat 1991; 19: 248-53
48. Ratey J, Greenberg M, Lindem K. Combination of treatments for attention deficit disorders in adults. J Nerv Ment Dis 1991; 176: 699-701
49. Pomerleau O, Downey K, Stelson F, et al. Cigarette smoking in adult patients diagnosed with ADHD. J Subst Abuse 1996; 7: 373-8
50. Conners C, Levin ED, Sparrow E, et al. Nicotine and attention in adult attention deficit hyperactivity disorder. Psychopharmacol Bull 1996; 32: 67-73
51. Rapport MD, Carlson GA, Kelly KL, et al. Methylphenidate and desipramine in hospitalized children. I. Separate and combined effects on cognitive function. J Am Acad Child Adolesc Psychiatry 1993; 32: 333-42
52. Gammon GD, Brown TE. Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacol 1993; 3: 1-10
53. Aranow RB, Hudson JL, Pope HG, et al. Elevated antidepressant plasma levels after addition of fluoxetine. Am J Psychiatry 1989; 146: 911-3
54. Wilens T, McDermott S, Biederman J, et al. Combined cognitive therapy and pharmacotherapy for adults with attention deficit hyperactivity disorder: a systematic chart review of 26 cases. J Cognit Psychother. In press
55. Zametkin AJ, Rapoport JL. Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years? J Am Acad Child Adolesc Psychiatry 1987; 26: 676-86
56. Elia J, Borcherding BG, Potter WZ, et al. Stimulant drug treatment of hyperactivity: biochemical correlates. Clin Pharmacol Ther 1990; 48: 57-66